Search
ZimVie Inc
ZIMVAdd to Watchlist
18.990USD
0.0000.00%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
535.46MMarket Cap
LossP/E TTM
More Details of ZimVie Inc Company
ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.
ZimVie Inc Info
Ticker SymbolZIMV
Company nameZimVie Inc
IPO dateFeb 14, 2022
CEOMr. Vafa Jamali
Number of employees1770
Security typeOrdinary Share
Fiscal year-endFeb 14
Address4555 Riverside Drive
CityPALM BEACH GARDENS
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code33410
Phone18003425454
Websitehttps://www.zimvie.com/en
Ticker SymbolZIMV
IPO dateFeb 14, 2022
CEOMr. Vafa Jamali
Company Executives of ZimVie Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Marissa Bych
Ms. Marissa Bych
Investor Relations
Investor Relations
--
--
Mr. Bryan Alterman
Mr. Bryan Alterman
Executive Officer, Director
Executive Officer, Director
--
--
Mr. Andre-Michel Ballester
Mr. Andre-Michel Ballester
Executive Officer, Director
Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Marissa Bych
Ms. Marissa Bych
Investor Relations
Investor Relations
--
--
Mr. Bryan Alterman
Mr. Bryan Alterman
Executive Officer, Director
Executive Officer, Director
--
--
Mr. Andre-Michel Ballester
Mr. Andre-Michel Ballester
Executive Officer, Director
Executive Officer, Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2022
FY2021
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
U.S.
67.96M
58.25%
Other countries
34.85M
29.87%
Spain
13.86M
11.88%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, May 4
Updated: Mon, May 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Heppenstall (Richard)
0.43%
Kanaglekar (Indraneel)
0.22%
Keeley-Teton Advisors, LLC
0.10%
UBS Fund Management (Switzerland) AG
0.04%
Asar (Vinit K.)
0.03%
Other
99.18%
Shareholders
Shareholders
Proportion
Heppenstall (Richard)
0.43%
Kanaglekar (Indraneel)
0.22%
Keeley-Teton Advisors, LLC
0.10%
UBS Fund Management (Switzerland) AG
0.04%
Asar (Vinit K.)
0.03%
Other
99.18%
Shareholder Types
Shareholders
Proportion
Individual Investor
0.77%
Investment Advisor
0.10%
Investment Advisor/Hedge Fund
0.04%
Other
99.09%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
560
332.94K
1.18%
-34.09M
2025Q4
584
20.99M
74.44%
-8.53M
2025Q3
576
26.10M
92.56%
-564.39K
2025Q2
582
24.71M
87.74%
-3.44M
2025Q1
619
24.56M
87.95%
-4.12M
2024Q4
657
24.97M
90.24%
-4.69M
2024Q3
687
25.93M
94.00%
-10.32M
2024Q2
743
26.64M
97.56%
-10.71M
2024Q1
810
25.96M
95.32%
-13.72M
2023Q4
813
25.52M
94.21%
-11.75M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Heppenstall (Richard)
122.11K
0.43%
--
--
Aug 25, 2025
Kanaglekar (Indraneel)
62.85K
0.22%
+1.43K
+2.32%
Aug 25, 2025
Keeley-Teton Advisors, LLC
27.57K
0.1%
-1.62K
-5.54%
Mar 31, 2025
UBS Fund Management (Switzerland) AG
11.59K
0.04%
+11.59K
--
Jun 30, 2025
Asar (Vinit K.)
7.89K
0.03%
+7.89K
--
Aug 25, 2025
Crawford (Sally W.)
7.89K
0.03%
-40.13K
-83.56%
Oct 20, 2025
Kuntz (Richard P)
7.89K
0.03%
+7.89K
+263000.00%
Aug 25, 2025
Matusinec (Karen)
7.89K
0.03%
+7.89K
--
Aug 25, 2025
Avantis Investors_NLE
1.12K
0%
+84.00
+8.08%
Mar 31, 2025
Lindbrook Capital, LLC
151.00
0%
+115.00
+319.44%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Dimensional US Core Equity 1 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Vanguard US Value Factor ETF
0%
iShares Russell 2000 Value ETF
0%
DFA Dimensional US Small Cap Value ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
State Street SPDR S&P Health Care Equipment ETF
0%
Vanguard US Multifactor ETF
0%
Avantis US Equity ETF
0%
iShares Russell 3000 ETF
0%
View more
Dimensional US Core Equity 1 ETF
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
Vanguard US Value Factor ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
DFA Dimensional US Small Cap Value ETF
Proportion0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0%
State Street SPDR S&P Health Care Equipment ETF
Proportion0%
Vanguard US Multifactor ETF
Proportion0%
Avantis US Equity ETF
Proportion0%
iShares Russell 3000 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
